About Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia
During the past decade, Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia
According to Clinical.Site data, the most researched conditions in "Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia" are
"AML, Adult" (1 trials), "Acute Lymphoid Leukemia" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia" in a lesser frequency.
Clinical Trials Intervention Types at Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia
Most popular intervention types in "Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia" are "Drug" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "IDH mutation test performed at diagnosis or relapse until January 31st, 2019." (1 trials), "Inotuzumab Ozogamicin (IO)" (1 trials) and "Venetoclax plus HMA" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia
The vast majority of trials in "Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia" are
3 trials for "All" genders.
Clinical Trials Status at Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia
Currently, there are NaN active trials in "Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".